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Abstract
The aim of this study was to analyze the metabolome of several Klebsiella pneumoniae
strains characterized by different resistance patterns. A total of 59 bacterial strains (27 car-
bapenemase-negative and 32 carbapenemase-positive) were included and their metabolic
features were assessed in basal conditions. Moreover, 8 isolates (4 wild-type and 4 KPC-
producers) were randomly selected to evaluate the impact of sub-lethal concentrations of
meropenem on bacterial metabolism. The metabolomic analysis was performed by 1H-NMR
spectroscopy both on filtered supernatants and cell lysates. A total of 40 and 20 molecules
were quantified in the intracellular and the extracellular metabolome, respectively. While in
basal conditions only five metabolites showed significant differences between carbapene-
mase-positive and negative strains, the use of meropenem had a profound impact on the
whole bacterial metabolism. In the intracellular compartment, a reduction of different over-
flow metabolites and organic acids (e.g. formate, acetate, isobutyrate) was noticed,
whereas, in the extracellular metabolome, the levels of several organic acids (e.g. succi-
nate, acetate, formate, lactate) and amino acids (aspartate, threonine, lysine, alanine) were
modified by meropenem stimulation. Interestingly, carbapenemase-positive and negative
strains reacted differently to meropenem in terms of number and type of perturbed metabo-
lites. In wild-type strains, meropenem had great impact on the metabolic pathways related
to methane metabolism and alanine, aspartate and glutamate metabolism, whereas in
KPC-producers the effect was predominant on pyruvate metabolism. The knowledge about
the bacterial metabolic profiles could help to set up innovative diagnostic methods and new
antimicrobial strategies to fight the global crisis against carbapenemase-positive K.
pneumoniae.
Introduction
The global spread of carbapenemase-producing Enterobacteriaceae (CPE) is of great concern
to health services worldwide [1, 2]. In particular, multi-drug resistant Klebsiella pneumoniae
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strains, harboring KPC enzymes, have been causing epidemics of international proportions [3,
4]. Healthcare-associated infections caused by CPE represent an alarming and dramatic prob-
lem for different reasons. Firstly, most carbapenemase-encoding genes are located on transfer-
able genetic elements that are often associated with other antibiotic resistance genes, thus
leading to their rapid transfer and to the spread of multi-drug resistant superbugs [5].
Moreover, the morbidity associated to CPE infections is usually high, with a relevant clini-
cal and economic impact. Indeed, the mortality rate due to CPE infections is usually about 20–
30% and can reach 70% in case of bacteremia or pneumonia in critically ill patients [6].
Finally, the therapeutic options for CPE infections are few and limited to old and toxic
drugs, thus leading to the onset and spread of new resistance mechanisms (e.g. colistin resis-
tance) [7].
In the last years, several approaches have been proposed to fight the global burden of CPE.
On the one hand, screening and surveillance hospital protocols, as well as strict infection con-
trol measures (e.g. hand hygiene, patient isolation, personal protection equipment), have been
adopted. On the other hand, rapid laboratory assays for the identification of CPE and new
antimicrobials acting against KPC-producing Enterobacteriaceae (e.g. ceftazidime/avibactam)
have been introduced in the diagnostic and clinical practice, respectively [8–12].
Nevertheless, the global crisis against multi-drug resistant CPE is still ongoing and consti-
tutes a major public health challenge [13, 14]. For this reason, rapid and reliable diagnostic
approaches, as well as new antimicrobial drugs, are urgently needed for a better management
of CPE infections.
In this context, information about the metabolic profiles of CPE in basal conditions and
under ‘antibiotic stress’ could represent an intriguing approach to obtain useful information to
set up new diagnostic methods and to develop new antimicrobial strategies.
Proton-based nuclear magnetic resonance (1H-NMR) spectroscopy proved to be a fast and
reliable analytical technique to detect and quantify low molecular weight metabolites in differ-
ent matrices and biological fluids [15–17]. Moreover, it has been previously used to study the
intracellular and extracellular metabolic profiles of different Gram-positive (e.g. lactobacilli
and Staphylococcus aureus) and Gram-negative bacteria (e.g. Acinetobacter baumannii, Pseu-
domonas aeruginosa) [18–21].
It has been shown that data about the bacterial metabolome can be useful to get new
insights on the microbial physiology and pathogenesis, to find correlations with the taxonomy
and to distinguish bacterial strains on the basis of different growth patterns (e.g. planktonic vs
biofilm) or based on various antimicrobial resistance phenotypes (e.g. methicillin-resistant vs
methicillin-susceptible Staphylococcus aureus) [18–23].
The aim of this study was to characterize and compare the metabolic profiles of several car-
bapenemase-positive and carbapenemase-negative K. pneumoniae strains, by means of
1H-NMR spectroscopy, both in basal conditions and after the exposure to sub-lethal concen-
trations of meropenem. Major potential applications of this work concern the identification of
specific metabolic biomarkers able to differentiate K. pneumoniae strains with different resis-
tance patterns and the detection of critical metabolic pathways, to be used as potential targets
of novel antimicrobial drugs.
Materials and methods
Bacterial strains
K. pneumoniae strains were isolated from surveillance and clinical samples submitted to the
Microbiology Unit of S. Orsola-Malpighi University Hospital of Bologna (Italy) for routine
diagnostic procedures.
Klebsiella pneumoniae metabolome
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The bacterial identification at the species level was obtained by means of a matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), using the
VITEK MS system (bioMe´rieux), whereas antimicrobial susceptibility testing (AST) was per-
formed using Vitek AST-N 201 cards on a Vitek 2 automated instrument (bioMe´rieux).
EUCAST criteria (www.eucast.org) were used for the interpretation of results and for the
definition of antimicrobial susceptibility category. In the case of a strain resistant to a third-
generation cephalosporins (i.e. cefotaxime and/or ceftazidime), the production of extended-
spectrum β-lactamase enzymes was confirmed by double-disk synergy test [24]. Moreover, in
the case of a minimum inhibitory concentration (MIC) of meropenem > 0.25 mg/L, a combi-
nation disk testing (disks of meropenem ± various inhibitors) was performed, in order to con-
firm the positivity for carbapenemase and to define the type of enzyme produced [25].
Temocillin susceptibility testing was used for the detection of OXA-48-like enzymes [26].
Starting from overnight grown bacterial colonies, the presence of a carbapenemase was fur-
ther investigated by a genotypic method, based on the real-time amplification of the major car-
bapenemase genes (blaKPC, blaIMP, blaVIM, blaNDM and blaOXA-48), using a commercially
available assay (Xpert Carba-R, Cepheid).
For all the isolates, the exact MIC values of meropenem were calculated by means of a broth
micro-dilution assay, following CLSI guidelines [27].
Sample preparation
For each strain, bacteria were grown overnight in Mueller-Hinton (MH; Sigma-Aldrich) agar
at 37˚C in aerobic atmosphere. Afterwards, 400 μl of a 2 McFarland (McF) turbidity suspen-
sion (corresponding to 0.5 optical density [OD] at 550 nm) were inoculated into 5 mL of MH
broth and incubated under shaking for 6–8 hours at 37˚C. Each bacterial suspension was then
adjusted to the same turbidity value (2.8 McF, corresponding approximately to 8 × 108 colony
forming units/mL and 0.7 OD at 550 nm) by adding MH broth. One mL of the bacterial sus-
pension was centrifuged at 5,000 × g for 20 minutes at 4˚C in order to separate the cell pellet
from the supernatant. Then, supernatants were filtered through a 0.2 μm membrane filter to
obtain cell free supernatants and stored at -80˚C.
Cell pellets were then washed twice in sterile saline and internal metabolites were extracted
with cold methanol, following the protocol described by Park et al., with slight modifications
[28]. Briefly, the biomass pellets were suspended in 250 μL of 100% cold methanol (−20˚C)
and 250 μL of sterile saline, thoroughly vortexed and frozen at −80˚C for 30 minutes. After-
wards, the cell pellets were allowed to thaw on ice for 30 minutes. The freeze–thaw cycles were
repeated three times to cause the metabolites to leak from the cells. The suspensions were then
centrifuged at 13,000 × g for 10 min. The supernatants were collected and stored on dry ice,
whereas 500-μL aliquots of 100% cold methanol (250 μL) and sterile saline (250 μL) were
added to the pellets. The entire above procedure was repeated, then the two aliquots were com-
bined. Finally, the solutions were evaporated under reduced pressure and the samples were
stored at −80˚C.
At the time of metabolomic analysis, all the samples were gently thawed. Both the filtered
supernatants and the cell lysates were analyzed by 1H-NMR to examine the extracellular and
intracellular metabolome, respectively, as described below.
The same protocol was used to investigate the metabolic profile of 8 randomly selected K.
pneumoniae strains (4 wild-type isolates and 4 KPC-producers) under ‘antibiotic-stress’. In
particular, bacteria were allowed to grow for 6–8 hours in antibiotic-free MH broth and, in
parallel, in MH broth added from the beginning of the incubation with sub-lethal concentra-
tions (1/8 of the MIC value) of meropenem (Sigma-Aldrich).
Klebsiella pneumoniae metabolome
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As preliminary investigation, an evaluation of the bacterial growth curves in absence and in
presence of various sub-MIC levels of meropenem (1/2, 1/4 and 1/8 of the MIC values) was
performed by the measurement of the optical density values at different time points, at 550
nm. For a value of 1/8 of the MIC, the bacterial growth in presence of meropenem was compa-
rable to the cultures without antibiotic (S1 Fig). Therefore, 1/8 of the MIC was chosen for anti-
biotic exposure assays, as the highest sub-lethal dose of meropenem that did not affect the
bacterial growth.
After a sample size calculation based on previously published data [29], the 8 strains used
for antibiotic-exposure experiments were selected randomly, considering that the metabolic
profiles of the 59 K. pneumoniae isolates in basal conditions were very similar to each other
(see Results section). To assess whether the randomly selected strains were representative of
the corresponding groups, a rPCA model was calculated on all the strains and all the molecules
of the extracellular compartment (S2 Fig). A screen test allowed to observe that three compo-
nents offered the best compromise between variance explained and model complexity [30].
Along each of the three components, representing as much as the 74.8% of the total variance,
the samples selected never exceeded 1.5 times the interquartile range of the corresponding
group and could be therefore considered representative of the corresponding groups [31].
Metabolomic analysis
The metabolomic investigation was performed by means of 1H-NMR spectroscopy, starting
from the filtered supernatants (‘external metabolome’) and the cell lysates (‘internal
metabolome’).
For each K. pneumoniae strain, 700 μl of cell-free supernatant and 100 μl of cellular lysate
were added to 100 μl of a D2O solution of 3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid sodium
salt (TSP) 10 mM set to pH 7.0 ± 0.02 by means of a 1M phosphate buffer, containing also
NaN3 2 mM to avoid bacteria proliferation. Cellular lysate samples were also added with 600 μl
of deionized water, to meet the sample volume specifications of the NMR probe.
1H-NMR spectra were recorded at 298 K with an AVANCE III spectrometer (Bruker,
Milan, Italy) operating at a frequency of 600.13 MHz, equipped with Topspin software (Ver.
3.5) [17, 32]. The spectra were formed by 32K points, spanning a spectral width of 11.97 ppm,
registered for 256 scans. Each spectrum was then processed (alignment, baseline adjustment)
following the procedure previously described [17, 33, 34].
The signals were assigned by comparing their chemical shift and multiplicity with the
Human Metabolome Database [35] and the compounds library (Ver. 10) of Chenomx software
(Chenomx Inc., Canada, Ver. 8.3). Quantification of the molecules was performed in the first
sample acquired by employing the added TSP as an internal standard. In the case of cell-free
supernatant, the first sample was represented by the growth medium. In order to compensate
for differences in solids content, any other sample was then normalized to such sample by
means of probabilistic quotient normalization [36]. Integration of the signals was performed
for each molecule by means of rectangular integration.
Metabolic pathway analysis
MetaboAnalyst 3.0 (www.metaboanalyst.ca), a web server designed to permit comprehensive
metabolomic data analysis, was used to evaluate the impact of sub-lethal meropenem concen-
tration on the bacterial metabolic pathways [37].
The program is based on several databases, including KEGG (http://www.genome.jp/kegg/)
and the Human Metabolome Database (http://www.hmdb.ca/) and identifies the pathways
that are mostly perturbed.
Klebsiella pneumoniae metabolome
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The final list of altered metabolites that were significantly influenced by drug treatment,
was analyzed by Metabolomics Pathway Analysis (MetPA) software in MetaboAnalyst. The
built-in prokaryote (Escherichia coli K-12 MG1655) pathway library was used as reference.
The following pathways analysis algorithms were employed: the hypergeometric test for over-
representation analysis and the relative-betweenness centrality for pathway topology analysis
[38, 39].
The output of this program marks a metabolic pathway as significant if a significantly
higher number of compounds involved in that pathway is present in the input list than would
be expected by random chance. In the graphical outputs (metabolome view), each dot repre-
sents one metabolic pathway. The circle size and color shade of each circle are based on path-
way impact value and P-value (red being the most significant), respectively [38, 39].
Statistical analysis
All statistical analyses were performed by using R computational language (www.r-project.
org) and GraphPad Prism version 5.02 for Windows (GraphPad software).
Differences in the extracellular/intracellular metabolome composition between bacterial
groups were assessed by means of Kruskal-Wallis test, two-tailed paired or unpaired Wilcoxon
test or t-test, where appropriate (univariate analysis).
A robust principal component analysis (rPCA) (multivariate analysis) [40] was also per-
formed to obtain an overview of the differences between non-stimulated and meropenem-
stressed bacterial groups, on the basis of the significant metabolites found by means of the
univariate analysis. The scoreplot—the representation of the samples from the new point of
view—helps to visually inspect the trends underlying the samples, while the loadingplot (bar-
plot) evidences the molecules mainly driving the trends. Statistical significance was deter-
mined at P< 0.05.
Results
Bacterial strains
A total of 59 K. pneumoniae strains were included in the study. On the basis of AST and phe-
notypic test results, K. pneumoniae isolates were categorized in carbapenemase-positive
(n = 32) and carbapenemase-negative strains (n = 27). In particular, carbapenemase-positive
strains included 24 KPC-producers, 4 strains positive for metallo-β-lactamases (MBL; specifi-
cally 3 NDM and 1 VIM) and 4 isolates with OXA-48 enzymes. The class of carbapenemase
detected by phenotypic tests (combination disk testing) always agreed with the genotypic
detection (real-time PCR) of carbapenemase genes.
The group of carbapenemase-negative strains included 16 wild-type K. pneumoniae strains
and 11 ESBL-producers.
No significant differences were noticed with respect to bacterial growth between the differ-
ent groups of strains.
The full list of bacterial strains with the source of isolation, the type of enzyme detected and
the exact MIC values of meropenem are detailed in S1 Table.
Metabolomic analysis
Consistent with previous reports on similar matrices [18, 41], a total of 40 and 20 molecules
were detected and quantified by 1H-NMR analysis in the extracellular and intracellular meta-
bolome, respectively. These metabolites mainly belong to the families of amino acids, organic
acids and alcohols (S2 Table).
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In order to highlight significant differences in the metabolic profiles of K. pneumoniae
strains, different sets of analyses have been carried out, as follows: (i) in basal conditions, a
comparison between carbapenemase-positive (n = 32) and carbapenemase-negative strains
(n = 27), as well as between the three groups of strains harboring different types of carbapene-
mase (24 KPC, 4 MBL and 4 OXA-48), and between wild-type (n = 16) and ESBL-producing
strains (n = 11); (ii) an analysis of a group of 8 randomly selected strains in antibiotic-free con-
ditions and after meropenem exposure (1/8 of the MIC values), irrespective of the carbapene-
mase production; (iii) a comparison between non-stimulated and antibiotic-stressed bacteria,
stratified by the carbapenemase production. In particular, for theses latter analyses, 4 KPC-
producers (Kp08, Kp12, Kp15, Kp53) and 4 wild-type strains (Kp17, Kp25, Kp26, Kp61) were
considered.
The results of these three different sets of analyses are detailed in the following paragraphs.
(i) Metabolome of K. pneumoniae in basal conditions
Globally, the intracellular and extracellular metabolic profiles of the 59 K. pneumoniae strains
in basal conditions were rather similar. Indeed, in antibiotic-free conditions, we found 2
metabolites in the intracellular metabolome (betaine and isobutyrate) and 3 molecules in the
external metabolome (phenylalanine, sarcosine, valine), respectively, whose concentration dif-
fered significantly between carbapenemase-positive and carbapenemase-negative K. pneumo-
niae strains (Table 1). Similarly, in basal conditions, only 4 molecules showed significantly
different concentrations in the comparison between KPC, MBL and OXA-48 positive strains
(Table 2). Finally, two metabolites of the intracellular compartment (glutamate and acetate)
were found to be significantly different when the metabolic profiles of wild-type and ESBL-
positive strains were compared.
(ii) Metabolome of K. pneumoniae strains under ‘meropenem stress’
A total of 9 and 22 metabolites in the internal and external metabolome (S3 and S4 Tables),
respectively, showed significant variations in antibiotic-stressed bacteria compared to non-
stimulated strains, thus indicating that meropenem had globally a profound impact on the bac-
terial metabolism.
In the intracellular compartment, the most significant changes regarded the reduction of
different overflow metabolites and organic acids (e.g. formate, acetate, isobutyrate), with the
exception of succinate, showing higher levels after meropenem exposure.
When the extracellular metabolome was analyzed, it was possible to highlight that the levels
of several metabolites, mostly organic acids and amino acids, were modified by the merope-
nem stimulation. As examples, aspartate, threonine, lysine and 2-hydroxyisobutyrate were
secreted in significantly larger amounts, whereas a lower production of urocanate, succinate,
Table 1. List of metabolites whose concentration (mmol/L; mean ± SD) differed significantly between carbapenemase-positive (+) and carbapenemase-negative (-)
K. pneumoniae strains in basal conditions.
Metabolite Carbapenemase + Carbapenemase - Localization P
Betaine 0.0084 ± 0.0044 0.0053 ± 0.0041 intracellular 0.009
Isobutyrate 0.0026 ± 0.0009 0.0034 ± 0.0009 intracellular 0.005
Phenylalanine 2.056 ± 0.08 2.083 ± 0.11 extracellular 0.025
Sarcosine 0.028 ± 0.004 0.035 ± 0.023 extracellular 0.048
Valine 2.486 ± 0.26 2.667 ± 0.36 extracellular 0.047
https://doi.org/10.1371/journal.pone.0207478.t001
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acetate, ethanol, propionate and alanine was detected. Moreover, the antibiotic stimulation led
to a higher consumption of formate, lactate and maltose by the bacterial cells.
In order to investigate underlying trends in the metabolome subspace represented by these
molecules, their concentrations were employed as the base for a rPCA model. In the intracellu-
lar metabolome, PC1, explaining the 91.9% of the total variance, effectively accounted for the
stress connected to the presence of a meropenem, with non-stimulated strains appearing at
low PC1 scores and clearly separated from antibiotic-stressed K. pneumoniae isolates
(P<0.001) (Fig 1). The correlation between the concentration of each molecule and its impor-
tance over PC1 served as a handy way to rank the molecules in order of importance in deter-
mining such grouping. As pointed out in Fig 1, higher concentrations of succinate and lower
concentrations of isocaproate and glycerol were the most significant changes after the stimula-
tion with sub-lethal concentration of meropenem in the internal metabolome.
Similarly, in the external metabolome, non-stimulated strains were clearly separated from
meropenem-stressed isolates along PC1, explaining the 92.1% of the total variance (Fig 1).
Higher concentrations of hydroxyisobutirate, threonine and aspartate and lower concentra-
tions of succinate, acetate and citraconate were the main characteristics of the stimulated K.
pneumoniae strains in contrast to non-stimulated bacteria (Fig 1).
Considering globally the data about the bacterial cell lysates and the supernatants, the anal-
ysis with MetaboAnalyst allowed to identify the specific metabolic pathways most affected by
drug exposure.
As shown in Fig 2, the impact of meropenem on K. pneumoniae was dramatic: six metabolic
pathways showed significant P-value following exposure (top portion with y-axis higher or
equal to 5: glycine, serine and threonine metabolism; aminoacyl-tRNA biosynthesis; cyanoa-
mino acid metabolism; methane metabolism; valine, leucine and isoleucine biosynthesis; pyru-
vate metabolism), and four metabolic pathways showed great pathway impact (x-axis larger or
equal to 0.4: glycine, serine and threonine metabolism; methane metabolism; pyruvate metab-
olism; alanine, aspartate and glutamate metabolism).
(iii) Analysis of the metabolic response to meropenem of wild-type and
KPC-producing strains
As shown in Tables 3 and 4, the presence of sub-lethal concentration of meropenem led to dif-
ferent metabolic variations in the comparison between carbapenemase-negative (4 wild-type)
and carbapenemase-positive strains (4 KPC-producers), in terms of both number and type of
perturbed metabolites.
Indeed, in the group of wild type isolates, a total of 21 molecules was altered by the drug
exposure, whereas 26 metabolites showed significant changes in the group of KPC-producers
after meropenem stimulation. Among those molecules, 14 were altered in the two groups in
the same direction (increase/reduction), while several others were perturbed only in one of the
two groups (e.g. acetate in the intracellular metabolome of wild-type strains; urocanate and
cadaverine in the external metabolome of KPC-positive isolates).
Table 2. List of metabolites whose concentration (mmol/L; mean ± SD) differed significantly between KPC, MBL and OXA-48 K. pneumoniae strains in antibiotic-
free conditions.
Metabolite KPC MBL OXA-48 Localization P
Formate 0.07 ± 0.04 0.13 ± 0.07 0.122 ± 0.06 intracellular 0.02
Glycine 0.003 ± 0.001 0.001 ± 0.0006 0.002 ± 0.001 intracellular 0.03
Lactate 0.48 ± 0.24 0.85 ± 0.15 0.65 ± 0.19 extracellular 0.01
Propionate 1.25 ± 0.51 1.81 ± 0.06 1.48 ± 0.37 extracellular 0.03
https://doi.org/10.1371/journal.pone.0207478.t002
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Considering the altered metabolites, an analysis of the most affected metabolic pathways
was performed. In wild-type K. pneumoniae (Fig 3), three metabolic pathways were signifi-
cantly altered after the drug exposure (alanine, aspartate and glutamate metabolism; aminoa-
cyl-tRNA biosynthesis; pyruvate metabolism), and two showed great pathway impact
(methane metabolism; alanine, aspartate and glutamate metabolism).
Conversely, in KPC-producing strains (Fig 3), five metabolic pathways showed significant
P-values following meropenem stimulation (glycine, serine and threonine metabolism;
Fig 1. rPCA model calculated on the space constituted by the concentration of the intracellular (upper panel) and extracellular (lower panel) molecules
that significantly differed between non-stressed and meropenem-stressed bacterial strains. In the scoreplot (left), non-stressed strains and meropenem-
stressed strains are represented with black square and red dots respectively, with lines connecting each strain to the median of its group. In the barplot (right),
describing the correlation between the concentration of each molecule and its importance over PC1, dark gray bars highlight statistically significant
correlations (P<0.05). In the barplot, bars pointing to the left denote metabolites that were more abundant in non-stressed cells, while bars pointing to the right
denote molecules that were more abundant in meropenem-stressed bacteria.
https://doi.org/10.1371/journal.pone.0207478.g001
Klebsiella pneumoniae metabolome
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alanine, aspartate and glutamate metabolism; butanoate metabolism; C5-branched dibasic
acid metabolism; citrate cycle or tricarboxylic acid cycle) and one showed great pathway
impact (pyruvate metabolism).
Discussion
To the best of our knowledge, this is the first report about the analysis of the metabolic features
of several K. pneumoniae strains characterized by different resistance patterns before and after
the exposure to meropenem. Previous works have investigated the volatile metabolome of K.
pneumoniae in human blood or during in vitro growth, but none has examined the effect of
meropenem on these bacteria, divided according to carbapenemase production [42–44].
Fig 2. Metabolome view of the metabolic pathways altered after meropenem exposure in the group of the 8 selected K. pneumoniae
strains. Each dot represents a unique metabolic pathway, with the dot size corresponding to the pathway impact score and the dot color (red
being the most significant) corresponding to the–log(P) value.
https://doi.org/10.1371/journal.pone.0207478.g002
Klebsiella pneumoniae metabolome
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At first, we looked for differences in the metabolic profiles between carbapenemase-positive
and carbapenemase-negative K. pneumoniae strains in the absence of a meropenem exposure,
as well as between the strains harboring different types of carbapenemase. In basal conditions,
only few metabolites showed significant differences between these groups of isolates. This
result agrees with a previous report about S. aureus, demonstrating that without exposure to
antibiotics, the concentrations of only 5 metabolites varied significantly in comparison of iso-
genic pairs of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains [29].
Afterwards, we evaluated the global effect of sub-lethal concentrations of meropenem on
the bacterial metabolome. To this purpose, we randomly selected 4 wild-type K. pneumoniae
isolates and 4 strains positive for KPC enzymes, representing the commonest types of carbape-
nemase in many parts of the world [45].
Irrespective of the resistance pattern, the presence of meropenem induced profound pertur-
bations in the bacterial metabolome. Indeed, the exposure to meropenem led to significant
variations in the levels of different amino acids and organic acids with a great impact on sev-
eral metabolic pathways including pyruvate metabolism and alanine, aspartate and glutamate
metabolism.
It has been shown that β-lactams, besides their primary mechanism of action (i.e. inhibition
of cell-wall synthesis), cause subsequent metabolic changes that occur downstream of the
interaction of the antibiotic with their target, playing an important role in bacterial lethality
[46, 47].
Effectively, β-lactams display a strong perturbations on bacterial metabolic profiles with the
increase or decrease in the concentrations of several metabolites, suggesting that antibiotic
treatment have broad and complex effects on metabolism and do not simply quench all meta-
bolic activities [48].
Table 3. List of intracellular/extracellular metabolites that significantly differed after the exposure with sub-lethal concentrations of meropenem in the group of
carbapenemase-negative (wild-type) K. pneumoniae isolates. The concentration of metabolites is expressed as mmol/L (mean ± SD).
Metabolite No stress Meropenem stress Localization Variation P
Formate 0.057 ± 0.02 0.022 ± 0.004 intracellular # 0.04
Glycerol 0.012 ± 0.003 0.006 ± 0.001 intracellular # 0.04
Lysine 0.024 ± 0.007 0.033 ± 0.009 intracellular " 0.025
Acetate 0.142 ± 0.02 0.023 ± 0.004 intracellular # 0.004
Isobutyrate 0.003 ± 0.001 0.0006 ± 0.0002 intracellular # 0.02
Isocaproate 0.008 ± 0.002 0.001 ± 0.0007 intracellular # 0.02
Citraconate 0.018 ± 0.001 0.014 ± 0.001 extracellular # 0.008
Maltose 0.025 ± 0.006 0.006 ± 0.002 extracellular # 0.006
Lactate 0.642 ± 0.199 -0.038 ± 0.006 extracellular # 0.006
Threonine 0.396 ± 0.633 1.915 ± 0.482 extracellular " 0.006
Agmatine 0.449 ± 0.015 0.349 ± 0.031 extracellular # 0.02
Lysine 0.815 ± 0.958 2.050 ± 0.197 extracellular " 0.04
Aspartate 0.678 ± 0.667 1.695 ± 0.119 extracellular " 0.04
Sarcosine 0.030 ± 0.001 0.025 ± 0.003 extracellular # 0.04
Succinate 5.015 ± 0.975 1.900 ± 0.218 extracellular # 0.01
Glutamate 12.70 ± 0.200 12.38 ± 0.206 extracellular # 0.04
Acetone 0.050 ± 0.001 0.055 ± 0.0006 extracellular " 0.003
Acetate 14.15 ± 1.872 8.815 ± 0.931 extracellular # 0.01
Alanine 3.878 ± 0.379 3.215 ± 0.097 extracellular # 0.03
2-Hydroxyisobutyrate 0.051 ± 0.023 0.193 ± 0.006 extracellular " 0.002
Propionate 1.545 ± 0.477 0.284 ± 0.225 extracellular # 0.005
https://doi.org/10.1371/journal.pone.0207478.t003
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In agreement with our findings, it has been previously shown, that the exposure to lethal or
sub-lethal concentrations of β-lactams induces significant changes in metabolites involved in
several pathways, like glycolysis, acetate metabolism, tricarboxylic acid (TCA) cycle, NAD and
amino acids metabolism [48–50].
For example, in S. aureus, lethal doses of ampicillin induce a higher consumption of glu-
cose, glutamine, valine, leucine and tyrosine, as well as a higher secretion of aspartate, gluta-
mate, isobutyrate, acetate and pyruvate [49].
Similarly, in Escherichia coli, ampicillin leads to an increase of amino acids metabolites at
60 and 90 minutes post-treatment, as well as to higher concentrations of metabolites involved
in central carbon metabolism, as citrate and succinate [48].
Comparing these data with our results, we noticed that some modifications showed similar
trends (e.g. higher levels of pyruvate and aspartate), whereas others were opposed to those
described for E. coli and S. aureus (e.g. variations of succinate and glutamate).
It should be considered that the bacterial metabolic response to an antibiotic is not only
specific for each type of microorganism, but also depends on many other factors, as the type
and dose (lethal/sub-lethal concentrations) of antimicrobial and the time of the analysis fol-
lowing the drug treatment.
Table 4. List of intracellular/extracellular metabolites that significantly differed after the exposure with sub-lethal concentrations of meropenem in the group of
carbapenemase-positive (KPC) K. pneumoniae isolates. The concentration of metabolites is expressed as mmol/L (mean ± SD).
Metabolite No stress Meropenem stress Localization Variation P
Lactate 0.025 ± 0.005 0.009 ± 0.006 intracellular # 0.03
Glycerol 0.015 ± 0.003 0.006 ± 0.001 intracellular # 0.002
Succinate 0.010 ± 0.002 0.025 ± 0.004 intracellular " 0.02
Acetone 0.002 ± 0.0007 0.001 ± 0.0005 intracellular # 0.03
Ethanol 0.005 ± 0.001 0.0004 ± 0.0005 intracellular # 0.008
Isobutyrate 0.003 ± 0.001 0.0009 ± 0.0004 intracellular # 0.005
Isocaproate 0.008 ± 0.001 0.0008 ± 0.0004 intracellular # 0.001
5-Hydroxytryptophan 0.941 ± 0.182 0.573 ± 0.170 extracellular # 0.04
Fumarate 0.295 ± 0.080 0.114 ± 0.018 extracellular # 0.03
Urocanate 0.016 ± 0.003 0.001 ± 0.001 extracellular # 0.002
Citraconate 0.018 ± 0.001 0.014 ± 0.001 extracellular # 0.0004
Maltose 0.014 ± 0.002 0.006 ± 0.001 extracellular # 0.03
Lactate 0.735 ± 0.235 -0.041 ± 0.005 extracellular # 0.007
Serine 0.386 ± 0.260 2.125 ± 0.241 extracellular " 0.005
4-H-3-methoxymandelate 0.070 ± 0.008 0.055 ± 0.004 extracellular # 0.03
Threonine 0.154 ± 0.152 2.685 ± 0.248 extracellular " 0.0005
Lysine 0.463 ± 0.205 2.170 ± 0.08 extracellular " 0.0001
Cadaverine 2.783 ± 0.349 0.968 ± 0.136 extracellular # 0.0016
Aspartate 0.396 ± 0.362 1.825 ± 0.092 extracellular " 0.0026
Pyroglutamate 1.170 ± 0.03 1.113 ± 0.047 extracellular # 0.01
Succinate 4.830 ± 1.15 1.793 ± 0.145 extracellular # 0.01
Pyruvate 0.139 ± 0.196 1.092 ± 0.194 extracellular " 0.008
Acetate 14.78 ± 0.95 6.583 ± 0.614 extracellular # 0.0004
Alanine 4.055 ± 0.369 3.190 ± 0.093 extracellular # 0.01
2-Hydroxyisobutyrate 0.042 ± 0.013 0.192 ± 0.007 extracellular " 0.0006
Propionate 1.618 ± 0.100 -0.020 ± 0.031 extracellular # < 0.0001
https://doi.org/10.1371/journal.pone.0207478.t004
Klebsiella pneumoniae metabolome
PLOS ONE | https://doi.org/10.1371/journal.pone.0207478 November 15, 2018 11 / 17
Probably, the most interesting data concerned the assessment of the bacterial response to
meropenem, stratified by the capability of carbapenemase production (wild-type strains vs
KPC-producers).
It has been reported that KPC-producing K. pneumoniae strains differs from carbapene-
mase-negative due to the presence of the blaKPC gene, carried on large plasmids and typically
present in a Tn3-based transposon. This gene encodes for the KPC enzyme, responsible for
high levels of penicillin and cephalosporin resistance and variable carbapenem resistance and
it is usually accompanied by other drug resistance determinants (e.g. aminoglycosides, quino-
lones, trimethoprim and tetracyclines) [44, 51].
Hence, we hypothesized that even the exposure to sub-lethal levels of meropenem would
cause different modifications in the metabolome between carbapenemase-negative and posi-
tive isolates.
Indeed, the bacterial response to meropenem differed significantly between wild-type and
KPC-positive strains, in terms of type of altered metabolites and impaired metabolic pathways.
It has been previously shown that, after the exposure to sub-lethal doses of methicillin,
MRSA and MSSA strains have different metabolic reactions, regarding the type, the number
and the trend of change of metabolites, with great impact on different metabolic pathways.
Globally, the analysis suggested that the metabolic activities of MSSA strains were more sus-
ceptible to the perturbation of methicillin exposure compared to the MRSA strains [29, 52].
Conversely, in this work, we noticed that carbapenemase-positive K. pneumoniae strains
were not more resistant to the metabolic changes caused by meropenem compared to wild-
type isolates. Rather, even though in presence of common metabolic alterations, some varia-
tions were specific for KPC-producers and others acted as biomarkers for wild-type isolates.
We are fully aware that some limitations could have affected our results. Among all, the rel-
atively low sensitivity of 1H-NMR spectroscopy could have led to miss significant molecules in
Fig 3. Metabolome view of the metabolic pathways altered after meropenem exposure in the group of wild-type (left) and KPC-producing (right) K.
pneumoniae strains. Each dot represents a unique metabolic pathway, with the dot size corresponding to the pathway impact score and the dot color (red
being the most significant) corresponding to the–log(P) value.
https://doi.org/10.1371/journal.pone.0207478.g003
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the metabolome of K. pneumoniae strains with a partial representation of the metabolic path-
ways perturbed by the meropenem stimulation. As an order of magnitude, 1H-NMR has been
shown to detect metabolites with concentrations of at least 1 to 5 μM, higher than other meta-
bolomics platforms (e.g. mass spectrometry) [53–55]. On the other hand, it is worth emphasiz-
ing some important strengths of the metabolomic analysis by 1H-NMR: (i) it is an intrinsically
quantitative technique, (ii) the experimental protocol requires a very limited sample manipula-
tion, allowing to process a large number of samples simultaneously [15, 56].
Conclusions
In conclusion, the metabolomic analysis of the bacterial isolates by 1H-NMR allowed to detect
and quantify a list of molecules that significantly differed between carbapenemase-positive and
carbapenemase-negative strains, both in antibiotic-free conditions and under ‘meropenem
stress’.
The data obtained could serve to set up innovative diagnostic strategies based on metabolic
biomarkers, as well as to elucidate the action of β-lactams on the bacterial metabolome. The
knowledge about these cellular responses are essential for improving existing therapies and
identifying novel therapeutic approaches [46, 47]. In this way, it could be possible to open up
significant perspectives for the control of the spread of CPE, still representing a worrisome
emergency for public health structures and healthcare systems worldwide [57, 58].
Future perspectives will include the analysis of a larger panel of K. pneumoniae strains, eval-
uating the effect of different types of antimicrobials and various combinations of drugs on the
bacterial metabolome. Moreover, the study of the effect of lethal concentrations of beta-lac-
tams will allow the identification of the earliest and most abundant metabolites associated with
the bacterial death. In this way, innovative approaches for the evaluation of the effectiveness of
several antimicrobials against carbapenemase-positive K. pneumoniae could be possible.
Finally, it will be crucial to evaluate the metabolic profiles of K. pneumoniae strains getting
deeper insights into their genetic background (e.g. sequence types by MLST or distinction
between different classes of KPC enzymes), in order to understand if the observed data are lim-
ited to specific clones or, if they are common to bacterial isolates with different genetic origins.
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